Jeffrey Encinas

Jeffrey Encinas is a highly accomplished professional with a strong background in Immunology, Medicine, Genetics, and Molecular Biology.

He holds a Doctor of Philosophy (Ph.D.) in Immunology from Harvard University, a Master of Medical Sciences (M.M.Sc.) in Medicine from Harvard Medical School, and a Bachelor of Arts (B.A.) in Genetics and Molecular Biology from the University of California, Berkeley.

With an impressive track record, Jeffrey currently serves as the CEO and Founder of Anenti Therapeutics. Prior to this role, he held key positions in renowned pharmaceutical companies such as Sanofi, Novartis Pharma K.K., Boehringer Ingelheim, Telos Pharmaceuticals, Bayer Yakuhin, Ltd., and Sumitomo Pharmaceuticals Co., Ltd.

His experience spans from being a Department Head to a Senior Research Scientist, showcasing his versatile skill set and expertise in various aspects of the pharmaceutical industry.

Jeffrey Encinas's leadership and contributions have been instrumental in driving research, innovation, and open collaboration in both Japan and global pharmaceutical settings.